Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQsmental-health

GP KFPs / SAQs · mental-health

Anxiety disorders — KFP-style written assessment

KFP-style staged scenarios on anxiety disorders: screening and severity bands, excluding medical mimics, NICE stepped-care decisions, sertraline initiation with activation counselling, benzodiazepine limits in panic disorder, and measurement-based relapse prevention.

30 marks45 min3 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
Anxiety: screen with GAD-7, exclude the mimics, step care up — and keep measuring

KFP 1 (10 marks)

A 29-year-old teacher presents with six months of constant worry about work performance, difficulty controlling the worry, muscle tension and broken sleep. PHQ-9 is 6; GAD-7 is 8. She drinks five coffees daily. TFTs normal. [1] [16]

  1. Interpret her GAD-7 score — what does it support, what does it not exclude? (2) [2] [3]
  2. Which modifiable contributor deserves a trial before or alongside other treatment, and why? (2) [16]
  3. Outline NICE's step 1–2 plan for her. (5) [1]

Model answers

  1. A score of 8 falls below the cut-off of 10 that Cochrane pooling associates with sensitivity 0.64 / specificity 0.91 for GAD — so probability is lowered but not excluded; with six months of uncontrolled worry and somatic tension the clinical story supports GAD assessment regardless. The derivation study's sensitivity 89%/specificity 82% represents best-case; pooled real-world performance is more modest. [2] [3]
  2. Caffeine: systematic review shows a dose-dependent anxiogenic effect in healthy individuals, partly through caffeine-induced insomnia. Five cups daily is a plausible driver; a supervised reduction trial is free, safe and diagnostic. [16]
  3. Step 1: education about GAD and treatment options plus active monitoring — less severe presentations may improve with this alone. Step 2 if not improved: low-intensity interventions guided by preference — individual non-facilitated self-help (CBT-based materials), individual guided self-help (CBT materials supported by a trained practitioner over 5–7 sessions of 20–30 minutes), or CBT-principled psychoeducational groups. Review with repeat GAD-7 at each contact. [1]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References9ShowHide
  1. [2]Spitzer RL, Kroenke K, Williams JB et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of internal medicine, 2006.PMID 16717171
  2. [3]Aktürk Z, Hapfelmeier A, Fomenko A et al. Generalized Anxiety Disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults. The Cochrane database of systematic reviews, 2025.PMID 40130828
  3. [5]Lewis G, Duffy L, Ades A et al. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA). The lancet. Psychiatry, 2019.PMID 31543474
  4. [6]Cardoner N, Gutiérrez-Rojas L, Saiz P et al. Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. Frontiers in pharmacology, 2025.PMID 39989902
  5. [10]Farris SG, Derby L, Kibbey MM Getting comfortable with physical discomfort: A scoping review of interoceptive exposure in physical and mental health conditions. Psychological bulletin, 2025.PMID 40014537
  6. [12]Lewis G, Marston L, Duffy L et al. Maintenance or Discontinuation of Antidepressants in Primary Care. The New England journal of medicine, 2021.PMID 34587384
  7. [16]Nascimento AOD, Silva CECD, Silva MLD et al. The Effects of Caffeine on Anxiety Behavior in Healthy Individuals: A Systematic Review of the Literature. Stress and health, 2026.PMID 41549915
  8. [18]García Álvarez Á, Riera Serra P, Ricci-Cabello I et al. Effectiveness and safety of focused deprescribing interventions targeting specific drug classes in older adults across clinical settings. Age and ageing, 2026.PMID 42607278
  9. [1]Bandelow B, Allgulander C, Baldwin DS et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2023.PMID 35900161
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAdult depression — KFP-style written assessmentmental-healthNextFirst-episode psychosis — KFP-style written assessmentmental-health